✦ LIBER ✦

Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due tograss pollen

✍ Scribed by Marogna, Maurizio; Spadolini, Igino; Massolo, Alessandro; Berra, Daniele; Zanon, Pietro; Chiodini, Elena; Canonica, Giorgio Walter; Passalacqua, Giovanni

Book ID: 121779497
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 324 KB
Volume: 102
Category: Article
ISSN: 1081-1206
DOI: 10.1016/S1081-1206(10)60111-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety of once-daily budesonid

Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study

✍ Sheffer, Albert L.; Silverman, Mike; Woolcock, Ann J.; Díaz, Patricia V.; Lindbe 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 271 KB

Efficacy and safety of inhaled budesonid

Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in adult patients. Comparison with budesonide CFC

✍ E Vastagh; P Kuna; P Calistru; M.A Bogdan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 209 KB